US$ 22.85
glp 1 agonists natural sources Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential The Multifaceted Nature of GLP-1:
Description
The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

Do not reuse

These specific strains may help support insulin sensitivity, blood sugar balance, appetite regulation, and metabolic efficiency

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been studied for their cardiovascular benefits in type 2 diabetes

Trail Sequential Analysis (TSA) was used to evaluate the reality and authenticity

Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases
